📣 ACG 2024 begins tomorrow in Philadelphia, USA: come and meet the Echosens team at the booth N°873! We are excited to share the latest product innovations and introducing you to Next Generation #FibroScan at the booth! More information here ➡️ https://lnkd.in/epQi8ANQ #Liverhealthmatters
Echosens
Medizintechnik
Paris, Île-de-France 17.337 Follower:innen
We are shaping the future of liver health. Because Liver Health Matters.
Info
A pioneer in its field, Echosens significantly changed the practice of liver diagnosis with FibroScan®, the non-invasive gold standard solution for comprehensive management of liver health. FibroScan® is recognized worldwide as the reference for liver fibrosis and liver steatosis assessment with more than 4,200 peer-reviewed publications and 180 international guidelines recommendations. Echosens has made FibroScan® available in over 100 countries enabling millions of liver examinations worldwide. We are working hand in hand with physicians, medical academic research, pharmaceutical companies for patient identification and monitoring in NAFLD/NASH. As patient education is a major issue, we have created the "myliverexam" website that provides information about the role of the liver and why it is vital to the global health.
- Website
-
http://www.echosens.com
Externer Link zu Echosens
- Branche
- Medizintechnik
- Größe
- 201–500 Beschäftigte
- Hauptsitz
- Paris, Île-de-France
- Art
- Privatunternehmen
- Gegründet
- 2001
- Spezialgebiete
- Diagnostic non-invasif en hépatologie, Pionnier en Elastographie quantitative und Evaluation de la fibrose hépatique et de la cirrhose
Orte
Beschäftigte von Echosens
Updates
-
With 20 years of hands-on clinical experience using FibroScan®, our Chief Medical Officer, Dr. Victor de Lédinghen, MD, PhD, is now driving its future. His expertise is key in advancing the development of FibroScan®, ensuring it continues to lead in liver health diagnostics.
-
⏰5 Days Left! The Liver Health Super Shaper Award honors healthcare professionals transforming liver care. 🌟Winners will direct a $10,000 donation to a health charity of their choice. Nominate a deserving hero now and make a difference ➡️ https://lnkd.in/gYF2MyjA #LiverHealthMatters #FibroScan
-
📺 Non perdete il nostro prossimo #webinar il 22 ottobre alle 19:00 : Overview sull’utilizzo della #SpleenStiffness negli algoritmi diagnostici dell’ipertensione portale pesentato da esperti nella salute del fegato : Prof. Antonio Colecchia, Prof. Filippo Schepis e Prof. Angelo Armandi. Spiegheranno attraverso una rassegna storica come la misurazione della rigidità della #Milza, sia passata dall’utilizzo di un’onda di taglio a 50Hz nei primi studi ai 100Hz attuali, con l’algoritmo dedicato del #FibroScan® Expert 630 e, come i dati clinici ottenuti siano un marcatore correlato dell'ipertensione portale. 📍 Unisciti a noi: https://lnkd.in/e-Rz6QbT #LiverHealthMatters
-
Echosens is proud to honor those making monumental strides in liver disease management. Nominate exceptional healthcare heroes and help shine a spotlight on their groundbreaking work. 💡 Two deserving winners will each receive $10,000 for a health charity of their choice. Submit a nomination now ➡️ https://lnkd.in/gYF2MyjA #LiverHealthMatters #FibroScan
-
UEG Week 2024, organized by UEG - United European Gastroenterology, starts tomorrow in Vienna, Austria! We look forward to sharing the latest product innovations and showing you all FibroScan products at booth N°47! #UEGWeek #FibroScan #Liverhealthmatters
-
Rediscover NASH Club, a comprehensive journey through the management of MASLD/MASH, with 3 episodes on diagnosis, patient pathways and treatments, hosted by Europe's top experts in the field! ✴️ The episodes are now in English with available subtitles in French, Spanish, Italian and German. 👉 Access this valuable content for free and on-demand, allowing you to learn at your own pace and convenience: https://www.nash-club.com/ #LiverHealthMatters #FibroScan #MASH
-
Did you know that October is Liver Cancer Awareness Month? It provides a key reminder of the importance of screening and ongoing monitoring of liver health to ensure early detection of the most common type of primary liver cancer in adults, hepatocellular carcinoma (HCC). Today, liver cancer remains a global health problem, with an estimated incidence of over one million cases by 2025. Fortunately, a number of chronic liver diseases can be slowed down or reversed if diagnosed at an early stage, thanks to the expertise and commitment of healthcare professionals. Learn more here 👉 https://lnkd.in/dFkYp83 #LiverHealthMatters #FibroScan
-
🎉 Celebrate the healthcare professionals transforming liver health with the Liver Health Super Shaper Award! Winners receive a $10,000 donation to their chosen health charity, courtesy of Echosens. ➡️ Nominate a colleague who deserves recognition today: https://lnkd.in/gYF2MyjA
-
Nous sommes présents dès aujourd'hui à l'AFEF 2024, qui se déroule cette année à Antibes jusqu'au 4 octobre. Retrouvez-nous sur le stand N°2 pour assister aux démos de nos dernières innovations produits #FibroScan. Nous sommes impatients de vous rencontrer ! #LiverHealthMatters #AFEF2024 AFEF - Société Française d'Hépatologie